(Image courtesy of The White House)
The federal government wants U.S. diagnostics companies to develop rapid point-of-care COVID-19 antibody tests — using only materials made in the USA.
The Department of Health and Human Services (HHS) on Thursday issued the call for submissions from companies that can quickly begin production of more than 20 million such tests per month. The tests must be suitable for use by non-professionals, accurate and low-cost.
Get the full story on our sister site, Medical Design & Outsourcing.